title: Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic (5HT1 and 5HT2) receptors in dog brain and aorta.
authors.forename: T
authors.initials: T
authors.lastname: Nagatomo
authors.forename: R
authors.initials: R
authors.lastname: Hokibara
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: J
authors.initials: J
authors.lastname: Aono
authors.forename: H
authors.initials: H
authors.lastname: Tsuchihashi
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D004285:Dogs; D005260:Female; D066298:In Vitro Techniques; D007650:Ketanserin / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D011799:Quinazolines / Q000494:pharmacology*; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*
chemical_list: D000319:Adrenergic beta-Antagonists; D011799:Quinazolines; D011985:Receptors, Serotonin; D012701:Serotonin; C042712:SGB 1534; D007650:Ketanserin